PAK1 regulates oligodendroglial proliferation and repopulation in homeostatic and demyelinating brain

Yan Wang1, Bokyung Kim1, Xiangyi Shi1

  • 1Department of Neurology, UC Davis School of Medicine; Institute for Pediatric Regenerative Medicine (IPRM), Shriners Hospitals for Children, 2425 Stockton Blvd., Sacramento, CA, 95817, USA.

Insights

Activating mutations in p21-activated kinase 1 (PAK1) stall oligodendrocyte progenitor cells (OPCs) in a proliferative state, impacting brain development and white matter repair. PAK1 inhibition impairs OPC regeneration after injury.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Developmental Biology

Background:

  • Activating mutations in p21-activated kinase 1 (PAK1) are linked to neurodevelopmental disorders in children.
  • Oligodendroglial lineage cells, crucial for brain development and white matter integrity, undergo significant proliferation postnatally.
  • The role of PAK1 in regulating oligodendroglial development remains largely unexplored.

Purpose of the Study:

  • To investigate the role of PAK1 in oligodendroglial progenitor cell (OPC) proliferation and regeneration.
  • To determine how PAK1 activity influences OPCs during normal brain development and in response to white matter injury.
  • To explore PAK1 as a potential therapeutic target for demyelinating lesions.

Main Methods:

  • Utilized genetic mouse models with specific PAK1 deletion or kinase inhibition in OPCs.
  • Assessed OPC proliferation, population expansion, and differentiation capacity in homeostatic and injured brain conditions.
  • Analyzed PAK1 kinase activity in OPCs and its modulation of PDGFRa-mediated signaling.

Main Results:

  • OPCs exhibit high PAK1 kinase activity, maintaining a proliferative progenitor state by modulating PDGFRa signaling and inhibiting differentiation.
  • PAK1 deficiency or inhibition in OPCs leads to reduced proliferation and population expansion in a cell-autonomous manner.
  • OPC-specific PAK1 deletion or inhibition impairs OPC proliferation and regeneration following white matter injury.

Conclusions:

  • Kinase-activating PAK1 mutations can stall OPCs, hindering timely oligodendroglial differentiation and contributing to CNS abnormalities in affected children.
  • PAK1 plays a critical role in regulating OPC proliferation and regeneration in both normal development and white matter injury.
  • PAK1 represents a potential molecular target for strategies aimed at replenishing OPCs in demyelinating lesions.